Duggan DV8 Dog Worming Tablets 10pk

INDICATIONS FOR USE
Treatment of mixed infections by nematodes and cestodes of the following species and life stages of parasite:
Nematodes:
Ascarids: Toxocara canis, Toxacaris leonina (L5 and adluits)
Hookworms: Ancylostoma caninum, Uncinaria stenocephala (adults)
Whipworms: Trichuris vulpis (adults)
Cestodes:
Tapeworm: Diphylidium caninum, Taenia hydatigena,
Taenia pisiformis, Echinococcus granulosus (adult and late immature forms)
The veterinary medicinal product is exclusively indicated when used against gastrointestinal nematodes and cestodes is indicated at the same time.

DOSE RATE
For oral treatment only.
The recommended dose is 1 tablet/10 kg bw (equivalent to 5mg/kg praziquantel, 14.4mg/kg pyrantel embonate and 20mg/kg fenbendazole.)
For routine treatment, a single dose is sufficient.
In case of a diagnosed helminthosis, the treatment should be repeated in 14 days. To ensure administration of a correct dose, body weight should be determined as accurately as possible.

METHOD OF ADMINISTRATION
The tablet can be given directly for oral administration or crushed and mixed into the feed. The animal does not need to be fasted during the treatment. For control of Toxocara canis, nursing bitches should be dosed 2 weeks after giving birth and every two weeks until weaning. In some cases, deworming frequency may be higher (lactating bitches, young dogs < 6 months of age). In such cases consult your veterinarian in order to establish an appropriate deworming protocol.

ADVERSE REACTIONS
Gastrointestinal disorders (vomiting and diarrhoea) and nonspecific signs such as lethargy, anorexia or hyperactivity can occur very rarely.

SPECIAL WARNINGS & PRECAUTIONS FOR USE
Special precautions for use in target species:

Please refer to the product SPC section 4.4 & 4.5 for a complete list of warnings & precautions.
Fleas serve as intermediate hosts for one common type of  tapeworm – Diphylidium caninum. Tape worm infestation is certain to reoccur unless control of intermediate hosts such as fleas, mice, etc is undertaken. Care should be taken to avoid the development of parasite resistance. Suspected cases of parasite resistance should be further investigated using appropriate tests (e.g Faecal Egg Count Reduction Test). To minimise the risk of re-infestation and new infestation, excreta should be collected and properly disposed of for 24
hours following treatment. Not to be used in puppies under 2 weeks of age or weighing less than 1 kg. Special precautions to be taken by the person administering the veterinary medicinal product to animals. Please refer to the product SPC section 4.5 for a compete list of precautions.
Partially unused half tablets should be returned to the open blister pack and stored in the carton. In case of accidental ingestion, particularly by children, seek medical advice immediately and show the package leaflet or the label to the physician. People with known hypersensitivity to the active ingredients should avoid contact with the veterinary medicinal product. Wash hands after sue.

USE DURING PREGNANCY, LACTATION OR LAY
The safety of the veterinary medicinal product has not been established during the early pregnancy in dogs. Do not use in pregnant bitches during the 1st and 2nd trimesters of pregnancy. After this time and during lactation use only according to the risk benefit assessment by a veterinarian. In breeding dogs use only according to the benefit risk assessment by a veterinarian.

INTERACTION WITH OTHER MEDICINAL PRODUCTS AND
OTHER FORMS OF INTERACTION
Do not use simultaneously with piperazine compounds as the anthelmintic effects of pyrantel and piperazine may be antagonized. Equally, do not administer together with organic phosphates and diethylcarbamazine. Pleaserefer to the product SPC section 4.8 for a complete list of interactions.

WITHDRAWAL PERIODS
Not applicable.

ADDITIONAL INFORMATION
All active ingredients of the product have an antiparasitic effect with different mode of action. The veterinary medicinal product is a broad spectrum anthelmintic and is effective against the following species: Toxacara canis, Toxacara leonine, Ancylostoma caninum, Uncinaria stenocephala, Trichuris vulpis, Diphylidium caninum, Taenia hydatigena, Taenia pisiformis and Echinococcus granulosus species. In this fixed combination pyrantel and fenbendazole act synergistically against Toxocara canis in dogs.